Franklin Resources’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7M | Sell |
649,138
-314,143
| -33% | -$9.03M | ﹤0.01% | 947 |
|
|
2025
Q1 | $32.3M | Sell |
963,281
-628,385
| -39% | -$21.1M | 0.01% | 745 |
|
|
2024
Q4 | $81.4M | Buy |
1,591,666
+201,556
| +14% | +$10.3M | 0.02% | 466 |
|
|
2024
Q3 | $73.8M | Buy |
1,390,110
+528,688
| +61% | +$28.1M | 0.02% | 479 |
|
|
2024
Q2 | $38.6M | Buy |
861,422
+448,213
| +108% | +$20.1M | 0.01% | 634 |
|
|
2024
Q1 | $19.3M | Hold |
413,209
| – | – | 0.01% | 879 |
|
|
2023
Q4 | $14.7M | Buy |
413,209
+274,384
| +198% | +$9.76M | 0.01% | 838 |
|
|
2023
Q3 | $4.13M | Buy |
138,825
+34
| +0% | +$1.01K | ﹤0.01% | 1142 |
|
|
2023
Q2 | $2.5M | Buy |
138,791
+261
| +0.2% | +$4.7K | ﹤0.01% | 1329 |
|
|
2023
Q1 | $2.22M | Buy |
+138,530
| New | +$2.22M | ﹤0.01% | 1331 |
|